These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 33789881

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells.
    Kwan WH, van der Touw W, Paz-Artal E, Li MO, Heeger PS.
    J Exp Med; 2013 Feb 11; 210(2):257-68. PubMed ID: 23382542
    [Abstract] [Full Text] [Related]

  • 6. Tumor hypoxia is associated with resistance to PD-1 blockade in squamous cell carcinoma of the head and neck.
    Zandberg DP, Menk AV, Velez M, Normolle D, DePeaux K, Liu A, Ferris RL, Delgoffe GM.
    J Immunother Cancer; 2021 May 11; 9(5):. PubMed ID: 33986123
    [Abstract] [Full Text] [Related]

  • 7. Immune cell-derived C3a and C5a costimulate human T cell alloimmunity.
    Cravedi P, Leventhal J, Lakhani P, Ward SC, Donovan MJ, Heeger PS.
    Am J Transplant; 2013 Oct 11; 13(10):2530-9. PubMed ID: 24033923
    [Abstract] [Full Text] [Related]

  • 8. STAT3 Modulation of Regulatory T Cells in Response to Radiation Therapy in Head and Neck Cancer.
    Oweida AJ, Darragh L, Phan A, Binder D, Bhatia S, Mueller A, Court BV, Milner D, Raben D, Woessner R, Heasley L, Nemenoff R, Clambey E, Karam SD.
    J Natl Cancer Inst; 2019 Dec 01; 111(12):1339-1349. PubMed ID: 30863843
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Absence of signaling into CD4⁺ cells via C3aR and C5aR enables autoinductive TGF-β1 signaling and induction of Foxp3⁺ regulatory T cells.
    Strainic MG, Shevach EM, An F, Lin F, Medof ME.
    Nat Immunol; 2013 Feb 01; 14(2):162-71. PubMed ID: 23263555
    [Abstract] [Full Text] [Related]

  • 11. Targeting C3a/C5a receptors inhibits human mesangial cell proliferation and alleviates immunoglobulin A nephropathy in mice.
    Zhang Y, Yan X, Zhao T, Xu Q, Peng Q, Hu R, Quan S, Zhou Y, Xing G.
    Clin Exp Immunol; 2017 Jul 01; 189(1):60-70. PubMed ID: 28295247
    [Abstract] [Full Text] [Related]

  • 12. Novel Effector Phenotype of Tim-3+ Regulatory T Cells Leads to Enhanced Suppressive Function in Head and Neck Cancer Patients.
    Liu Z, McMichael EL, Shayan G, Li J, Chen K, Srivastava R, Kane LP, Lu B, Ferris RL.
    Clin Cancer Res; 2018 Sep 15; 24(18):4529-4538. PubMed ID: 29712685
    [Abstract] [Full Text] [Related]

  • 13. CD244 represents a new therapeutic target in head and neck squamous cell carcinoma.
    Agresta L, Lehn M, Lampe K, Cantrell R, Hennies C, Szabo S, Wise-Draper T, Conforti L, Hoebe K, Janssen EM.
    J Immunother Cancer; 2020 Mar 15; 8(1):. PubMed ID: 32217758
    [Abstract] [Full Text] [Related]

  • 14. Resistance to Radiotherapy and PD-L1 Blockade Is Mediated by TIM-3 Upregulation and Regulatory T-Cell Infiltration.
    Oweida A, Hararah MK, Phan A, Binder D, Bhatia S, Lennon S, Bukkapatnam S, Van Court B, Uyanga N, Darragh L, Kim HM, Raben D, Tan AC, Heasley L, Clambey E, Nemenoff R, Karam SD.
    Clin Cancer Res; 2018 Nov 01; 24(21):5368-5380. PubMed ID: 30042205
    [Abstract] [Full Text] [Related]

  • 15. Deficiency of Complement C3a and C5a Receptors Prevents Angiotensin II-Induced Hypertension via Regulatory T Cells.
    Chen XH, Ruan CC, Ge Q, Ma Y, Xu JZ, Zhang ZB, Lin JR, Chen DR, Zhu DL, Gao PJ.
    Circ Res; 2018 Mar 30; 122(7):970-983. PubMed ID: 29437833
    [Abstract] [Full Text] [Related]

  • 16. Complement inhibition alleviates paraquat-induced acute lung injury.
    Sun S, Wang H, Zhao G, An Y, Guo Y, Du L, Song H, Qiao F, Yu H, Wu X, Atkinson C, Jiang S, Tomlinson S, Zhou Y.
    Am J Respir Cell Mol Biol; 2011 Oct 30; 45(4):834-42. PubMed ID: 21421909
    [Abstract] [Full Text] [Related]

  • 17. C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt/β-catenin signaling pathway in diabetic kidney disease.
    Li L, Chen L, Zang J, Tang X, Liu Y, Zhang J, Bai L, Yin Q, Lu Y, Cheng J, Fu P, Liu F.
    Metabolism; 2015 May 30; 64(5):597-610. PubMed ID: 25682062
    [Abstract] [Full Text] [Related]

  • 18. Deficiency of Complement C3a and C5a receptors Does Not Prevent Angiotensin II-Induced Hypertension and Hypertensive End-Organ Damage.
    Bode M, Herrnstadt GR, Dreher L, Ehnert N, Kirkerup P, Lindenmeyer MT, Meyer-Schwesinger CF, Ehmke H, Köhl J, Huber TB, Krebs CF, Steinmetz OM, Wiech T, Wenzel UO.
    Hypertension; 2024 Jan 30; 81(1):138-150. PubMed ID: 37909169
    [Abstract] [Full Text] [Related]

  • 19. Host derived macrophage migration inhibitory factor expression attenuates anti-tumoral immune cell accumulation and promotes immunosuppression in the tumor microenvironment of head and neck squamous cell carcinoma.
    Ryan N, Lamenza F, Shrestha S, Upadhaya P, Springer A, Jordanides P, Pracha H, Roth P, Kumar R, Wang Y, Vilgelm AE, Satoskar A, Oghumu S.
    Biochim Biophys Acta Mol Basis Dis; 2024 Oct 30; 1870(7):167345. PubMed ID: 38992847
    [Abstract] [Full Text] [Related]

  • 20. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
    Strauss L, Bergmann C, Szczepanski M, Gooding W, Johnson JT, Whiteside TL.
    Clin Cancer Res; 2007 Aug 01; 13(15 Pt 1):4345-54. PubMed ID: 17671115
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.